Floege J, Lafayette R, Barratt J, Schwartz B, et al. Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy. Kidney Int 2025 Jun 26:S0085-2538(25)00488-0. doi: 10.1016/j.kint.2025.
PMID: 40581166